Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Jiangsu Jibeier Pharmaceutical Co Net Margin %?
Jiangsu Jibeier Pharmaceutical CoSHSE:688566 -1.39%85 Net Margin % is 18.55% as of Mar. 2026, which is 18% below its 10-year median of 22.73. GuruFocus rates SHSE:688566 with a GF Score™ of 85/100 and a GF Value™ of ¥35.31 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 960 Drug Manufacturers companies, Jiangsu Jibeier Pharmaceutical Co ranks better than 92.29% on this metric.
The historical rank and industry rank for Jiangsu Jibeier Pharmaceutical Co's Net Margin % or its related term are showing as below:
SHSE:688566'
s Net Margin % Range Over the Past 10 Years
Min: 17.14 Med: 22.73 Max: 27.08
Current: 25.65
SHSE:688566's Net Margin % is ranked better than 92.29% of 960
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs SHSE:688566: 25.65
Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Jiangsu Jibeier Pharmaceutical Co Net Margin % Related Terms
Jiangsu Jibeier Pharmaceutical Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Jibeier Pharmaceutical Co Net Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Jibeier Pharmaceutical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangsu Jibeier Pharmaceutical Co Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jiangsu Jibeier Pharmaceutical Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Jiangsu Jibeier Pharmaceutical Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) has a Net Margin % of 18.55% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Jiangsu Jibeier Pharmaceutical Co and its competitors. This is 18% below median its historical median of 22.73. Over the past decade, Jiangsu Jibeier Pharmaceutical Co's Net Margin % has ranged from 17.14 to 27.08. According to the industry distribution chart, Jiangsu Jibeier Pharmaceutical Co ranks #74 out of 960 companies in the Drug Manufacturers industry, placing it in the top 7.7%.
Is Jiangsu Jibeier Pharmaceutical Co's Net Margin % too high?
Jiangsu Jibeier Pharmaceutical Co's current Net Margin % of 18.55% is 18% below median its 10-year median of 22.73. Over the past 10 years, this metric has ranged from a low of 17.14 to a high of 27.08. The Drug Manufacturers industry median Net Margin % is 5.56. Jiangsu Jibeier Pharmaceutical Co's value of 18.55% is 233.6% above this industry median. Based on the distribution chart, Jiangsu Jibeier Pharmaceutical Co ranks #74 out of 960 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Jiangsu Jibeier Pharmaceutical Co has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Jibeier Pharmaceutical Co's Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jiangsu Jibeier Pharmaceutical Co ranks #74 out of 960 companies for Net Margin %. This places Jiangsu Jibeier Pharmaceutical Co in the top 8% of its industry — outperforming the majority of peers. The industry median Net Margin % is 5.56. Jiangsu Jibeier Pharmaceutical Co's value of 18.55% is 233.6% above this benchmark. Historically, Jiangsu Jibeier Pharmaceutical Co's own Net Margin % has ranged from 17.14 to 27.08 over the past decade. While the company's 10-year median is 22.73 vs. the industry median of 5.56, Jiangsu Jibeier Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangsu Jibeier Pharmaceutical Co's current Net Margin % of 18.55% is 233.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Jiangsu Jibeier Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangsu Jibeier Pharmaceutical Co's current Net Margin % is 18.55%, which is 18% below median its own 10-year median of 22.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Jibeier Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥35.31, compared to a current price of ¥24.06 — trading 31.9% below its estimated fair value. The current Net Margin % is 18.55%, which is 18% below median its 10-year median of 22.73 and 233.6% above the Drug Manufacturers industry median of 5.56. Jiangsu Jibeier Pharmaceutical Co's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Jiangsu Jibeier Pharmaceutical Co (SHSE:688566), the current Net Margin % is 18.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangsu Jibeier Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥24.06 is trading 31.9% below its estimated GF Value™ of ¥35.31.
GuruFocus considers Jiangsu Jibeier Pharmaceutical Co to be Significantly Undervalued.
Key valuation signals for SHSE:688566:
Net Margin %: 18.55% (18% below median its 10-year median of 22.73)
GF Value™: ¥35.31 vs. price of ¥24.06 (31.9% below fair value)
Industry Position: 233.6% above the Drug Manufacturers median (#74 of 960)
No single metric tells the full story. See the SHSE:688566 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jiangsu Jibeier Pharmaceutical Co Business Description
Jiangsu Jibeier Pharmaceutical Co Ltd specializes in the research, development, production and sales of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products include tablets, hard capsules, eye drops, and gels, agents, creams and other dosage. Its products are used in various application fields such as Cardiovascular drugs, Blood system drugs, Immune system drugs, Ophthalmic drugs, Antipyretic and analgesic drugs, Respiratory medicine, and other.
85GF Score
Get the complete analysis for SHSE:688566
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688566 has been successfully added to your 
